These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27253660)

  • 1. A New Formulation of Oral Viscous Budesonide in Treating Paediatric Eosinophilic Oesophagitis: A Pilot Study.
    Oliva S; Rossetti D; Papoff P; Tiberti A; Rossi P; Isoldi S; Amil Dias J; Lucarelli S; Cucchiara S
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):218-224. PubMed ID: 27253660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis.
    Oliva S; Rossetti D; Papoff P; Tiberti A; Mallardo S; Volpe D; Ruggiero C; Russo G; Vezzoli D; Isoldi S; Cucchiara S
    Dig Dis Sci; 2019 Jun; 64(6):1571-1578. PubMed ID: 30659470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis.
    Miehlke S; Hruz P; Vieth M; Bussmann C; von Arnim U; Bajbouj M; Schlag C; Madisch A; Fibbe C; Wittenburg H; Allescher HD; Reinshagen M; Schubert S; Tack J; Müller M; Krummenerl P; Arts J; Mueller R; Dilger K; Greinwald R; Straumann A
    Gut; 2016 Mar; 65(3):390-9. PubMed ID: 25792708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
    Dohil R; Newbury R; Fox L; Bastian J; Aceves S
    Gastroenterology; 2010 Aug; 139(2):418-29. PubMed ID: 20457157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.
    Dellon ES; Katzka DA; Collins MH; Hamdani M; Gupta SK; Hirano I;
    Gastroenterology; 2017 Mar; 152(4):776-786.e5. PubMed ID: 27889574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children.
    Rubinstein E; Lee JJ; Fried A; Logvinenko T; Ngo P; McDonald D; Hait EJ
    J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):317-20. PubMed ID: 24821535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis.
    Rubinstein E; Hait EE; Mitchell PD; Lee JJ
    J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):395-397. PubMed ID: 28837508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis.
    Gupta SK; Vitanza JM; Collins MH
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):66-76.e3. PubMed ID: 24907502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
    Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide Oral Suspension Significantly Improves Eosinophilic Esophagitis Histology Scoring System Results: Analyses From a 12-Week, Phase 2, Randomized, Placebo-controlled Trial.
    Collins MH; Dellon ES; Katzka DA; Hirano I; Williams J; Lan L
    Am J Surg Pathol; 2019 Nov; 43(11):1501-1509. PubMed ID: 31498177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
    Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
    Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis.
    Dellon ES; Katzka DA; Collins MH; Gupta SK; Lan L; Williams J; Hirano I
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):666-673.e8. PubMed ID: 29902649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis.
    Philpott H; Nandurkar S; Royce SG; Thien F; Gibson PR
    Aliment Pharmacol Ther; 2016 May; 43(9):985-93. PubMed ID: 26939578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitis.
    Schlag C; Miehlke S; Heiseke A; Brockow K; Krug A; von Arnim U; Straumann A; Vieth M; Bussmann C; Mueller R; Greinwald R; Bajbouj M
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1122-30. PubMed ID: 26314389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pharmacokinetic Bridging Study to Compare Systemic Exposure to Budesonide between Budesonide Oral Suspension and ENTOCORT EC in Healthy Individuals.
    Song IH; Finkelman RD; Lan L
    Drugs R D; 2020 Dec; 20(4):359-367. PubMed ID: 33057953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
    Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
    Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia.
    Chan LJ; Tan L; Dhaliwal J; Briglia F; Clarkson C; Krishnan U
    Dis Esophagus; 2016 Aug; 29(6):563-71. PubMed ID: 25872589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
    Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
    Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children.
    Aceves SS; Bastian JF; Newbury RO; Dohil R
    Am J Gastroenterol; 2007 Oct; 102(10):2271-9; quiz 2280. PubMed ID: 17581266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.
    Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU
    Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.